Skip to Main Content

Randomized Trial of Adult Subjects With Generalized Anxiety Disorder

Conditions

Mental Health & Behavioral Research

Phase III

What is the purpose of this trial?

The purpose of this study is to compare the efficacy of BHV-4157 versus placebo in subjects with Generalized Anxiety Disorder.

  • Trial with
    Biohaven Pharmaceutical Inc.
  • Start Date
    04/30/2019
  • End Date
    10/19/2019
Trial Image

For more information about this study, contact:

David Zakur

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    08/01/2019
  • Study HIC
    #2000024951